BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mody K, Kasi PM, Yang J, Surapaneni PK, Bekaii-saab T, Ahn DH, Mahipal A, Sonbol MB, Starr JS, Roberts A, Nagy R, Lanman R, Borad MJ. Circulating Tumor DNA Profiling of Advanced Biliary Tract Cancers. JCO Precision Oncology 2019. [DOI: 10.1200/po.18.00324] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Chakrabarti S, Finnes HD, Mahipal A. Fibroblast growth factor receptor (FGFR) inhibitors in cholangiocarcinoma: current status, insight on resistance mechanisms and toxicity management. Expert Opinion on Drug Metabolism & Toxicology. [DOI: 10.1080/17425255.2022.2039118] [Reference Citation Analysis]
2 Wang SQ, Chai CX, Wang BR, Zhu F, Shang D, Li M. Liquid biopsy: Precise diagnosis and therapy for cholangiocarcinoma. World J Gastrointest Oncol 2022; 14(1): 362-365 [DOI: 10.4251/wjgo.v14.i1.362] [Reference Citation Analysis]
3 King G, Javle M. FGFR Inhibitors: Clinical Activity and Development in the Treatment of Cholangiocarcinoma. Curr Oncol Rep 2021;23:108. [PMID: 34269915 DOI: 10.1007/s11912-021-01100-3] [Reference Citation Analysis]
4 Shotton R, Lamarca A, Valle J, McNamara MG. Potential utility of liquid biopsies in the management of patients with biliary tract cancers: A review. World J Gastrointest Oncol 2021; 13(9): 1073-1085 [PMID: 34616513 DOI: 10.4251/wjgo.v13.i9.1073] [Reference Citation Analysis]